Sign inJoin waitlistJoin the waitlist

TW

Tzu-Fei Wang

Hematology

Credentials: · · ·

History

Hematology and Medical Oncology
Washington University/B-JH/SLCH Consortium
2010–2013
Ronald Reagan UCLA Medical Center
2007–2010
University of Minnesota Medical School
2003–2007
National Taiwan University, Taipei, Taiwan
1999–2003

Research

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
New England Journal of Medicine · 2018 · 1,199 citations
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study
Thrombosis and Haemostasis · 2018 · 167 citations
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018
Journal of the National Comprehensive Cancer Network · 2018 · 166 citations

Kristen Sanfilippo
20 papers
JZ
Jeffrey Zwicker
15 papers
Brian Gage
10 papers
AL
Avi Philip Sendzul Leader
8 papers
KC
Kenneth Carson
8 papers
Lisa Kreuziger
8 papers
Gerald Soff
7 papers
Jean Connors
7 papers
MG
Michael Grosso
6 papers
Brian Carney
5 papers
Manila Gaddh
5 papers
MS
Michael Streiff
5 papers

Clinical trials

A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg
Principal investigator · Recruiting · Phase 2, Phase 3
Ottawa Hospital Research Institute
2025–2027
Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
Principal investigator · Recruiting · Phase 4
Ottawa Hospital Research Institute
2024–2029
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Principal investigator · Recruiting · Phase 4
Tzu-Fei Wang
2022–2027
Statin Use in Patients With Acute VTE
Principal investigator · Terminated · Early phase 1
Ohio State University
2015–2020